EFFECT OF PLATELET-ACTIVATING-FACTOR ON BETA-ADRENOCEPTORS IN HUMAN-LUNG

[1] AGRAWAL DK, 1986, 2 INT C PAF GATL TN, P117

[2] INCREASED PULMONARY ALPHA-ADRENERGIC AND REDUCED BETA-ADRENERGIC RECEPTORS IN EXPERIMENTAL ASTHMA [J]. NATURE, 1980, 285 (5766) : 569 - 571

[3] DOWN-REGULATION OF BETA-2-ADRENERGIC RECEPTORS BY PAF-ACETHER AND ITS INHIBITION BY THE PAF-ACETHER ANTAGONIST BN-52021 [J]. PROSTAGLANDINS, 1985, 30 (04): : 721 - 721

[4] BRAQUET P, 1985, LANCET, V1, P1501

[5] CHENG JB, 1985, J PHARMACOL EXP THER, V232, P80

[6] CUSS FM, 1986, LANCET, V2, P189

[7] GRESELE P, 1985, LANCET, V1, P347

[8] SPECIFIC BINDING-SITES FOR PLATELET ACTIVATING FACTOR IN HUMAN-LUNG TISSUES [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 128 (02) : 972 - 979

[9] LEE TC, 1985, PHOSPHOLIPIDS CELLUL, V2, P1

[10] PAF-ACETHER - A MEDIATOR OF INFLAMMATION AND ASTHMA [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1984, 5 (06) : 239 - 241

[1] AGRAWAL DK, 1986, 2 INT C PAF GATL TN, P117

[2] INCREASED PULMONARY ALPHA-ADRENERGIC AND REDUCED BETA-ADRENERGIC RECEPTORS IN EXPERIMENTAL ASTHMA [J]. NATURE, 1980, 285 (5766) : 569 - 571

[3] DOWN-REGULATION OF BETA-2-ADRENERGIC RECEPTORS BY PAF-ACETHER AND ITS INHIBITION BY THE PAF-ACETHER ANTAGONIST BN-52021 [J]. PROSTAGLANDINS, 1985, 30 (04): : 721 - 721

[4] BRAQUET P, 1985, LANCET, V1, P1501

[5] CHENG JB, 1985, J PHARMACOL EXP THER, V232, P80

[6] CUSS FM, 1986, LANCET, V2, P189

[7] GRESELE P, 1985, LANCET, V1, P347

[8] SPECIFIC BINDING-SITES FOR PLATELET ACTIVATING FACTOR IN HUMAN-LUNG TISSUES [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 128 (02) : 972 - 979

[9] LEE TC, 1985, PHOSPHOLIPIDS CELLUL, V2, P1

[10] PAF-ACETHER - A MEDIATOR OF INFLAMMATION AND ASTHMA [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1984, 5 (06) : 239 - 241